Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

FDA: No ‘immediate significant impacts’ expected on supply due to Pfizer plant damage

Por: The Hill Health July 23, 2023

thumbnail

The Pfizer pharmaceutical plant this week in North Carolina will have no “immediate significant impacts” on drug supply chains, the Food and Drug Administration (FDA) said Friday. “We do not expect there to be any immediate significant impacts on supply given the products are currently at hospitals and in the distribution system, but this is a dynamic situation and FDA staff are in frequent communication with Pfizer and other... + full article



Similar News

Tornado damage to North Carolina Pfizer plant unlikely to cause significant drug supply impacts, FDA says

Fox Business USA Business July 23, 2023

thumbnailDr. Marty Makary discusses the FDA’s approval of new Alzheimer’s disease drug on ‘The Evening Edit.’ The commissioner of said Friday that the agency does not expect any immediate significant impacts on supply following damage from a tornado to a large Pfizer facility in... + más

Why Oklahoma tornado supercell was so unusual | Newsweek

The deadliest tornado in U.S. history | Newsweek


FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5

RTTNews USA Health March 15, 2023

thumbnailThe U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age.In a statement, the regulator said it has amended the emergency use authorization or EUA of the Pfizer-BioNTech... + más

FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews

Amid pathetic uptake, FDA green lights confusing COVID vaccine update for kids | Ars Technica


FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5

RTTNews USA Health March 15, 2023

thumbnailThe U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age.In a statement, the regulator said it has amended the emergency use authorization or EUA of the Pfizer-BioNTech... + más

FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews

Amid pathetic uptake, FDA green lights confusing COVID vaccine update for kids | Ars Technica


Fact Check: Were the Grammys sponsored by Pfizer?

Newsweek USA Business February 06, 2023

thumbnailPfizer's involvement with the 2023 Grammy Awards sparked speculation online, with some viewers wondering how much input the pharmaceutical company had.The annual music ceremony was held at the Crypto.com Arena in Los Angeles, California on Sunday night, with Beyoncé... + más

Here's how to watch the 2023 Grammys on iPhone, iPad, Apple TV, and more | 9to5Mac

Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy. | MarketWatch


Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.

MarketWatch USA Business February 04, 2023

thumbnailPfizer stock, too, has fallen out of favor, along with other Covid plays. At $44, it’s down 15% this year, making it one of the worst performers in the index. And it’s 30% below its late 2021 peak, badly trailing the rest of the drug group.   Now looks like the time to buy... + más

Fact Check: Were the Grammys sponsored by Pfizer? | Newsweek

Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history | CNBC


Pfizer accused of obscene COVID profits after posting record revenues

Newsweek USA Business February 02, 2023

thumbnailPharmaceutical giant Pfizer has been accused of making an obscene profit from the coronavirus pandemic after it posted record revenue of more than $100 billion for 2022, a rise of 23 percent on the previous year.The company's COVID products Comirnaty, an mRNA vaccine and... + más

Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history | CNBC

Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics | CNBC


Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history

CNBC USA Health December 06, 2022

thumbnailVials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate

Moderna is suing Pfizer over its coronavirus vaccine | The Verge



About iurex | Privacy Policy | Disclaimer |